Sector News

Report: Private equity firms eyeing Bayer MaterialScience

October 23, 2014
Chemical Value Chain
Private equity firms are mulling possible offers for Bayer MaterialScience (BMS), the German life science company’s major polyurethanes and polycarbonates business, according to a report on Reuters, citing sources familiar with the situation. Analysts have already speculated that BMS, which could be worth around €10 billion ($12.7 billion) on a debt-free basis when it is separated from Bayer next year, might also attract an industry buyer keen to establish a leadership position in BMS’s value-added plastics markets. 
 
> Read the full article on the Chemical Week website
 
By Natasha Alperowicz
 

Related News

September 18, 2020

British company Hydrachem launches Cert. – a household cleaner that destroys COVID-19 in just 60 seconds

Chemical Value Chain

A British company is today launching a household cleaner which destroys the SARS-CoV-2 virus – which causes COVID-19 – in just 60 seconds. Cert. is manufactured by Hydrachem, which has […]

September 18, 2020

European Commission raises EU’s GHG emissions reduction target to at least 55% by 2030

Chemical Value Chain

The European Commission presented today its 2030 climate target plan, in which it sets out a program to reduce EU greenhouse gas (GHG) emissions by at least 55% by 2030, […]

September 16, 2020

Dow to sell trio of US Gulf Coast tank terminals to Vopak JV for $620 million

Chemical Value Chain

Dow has agreed to sell three of its chemical storage terminals on the US Gulf Coast for $620 million to a joint venture (JV) between Vopak (Rotterdam, Netherlands) and investment […]